Biosyent Inc EBITDA Margin dropped on 33.3 pp from 33.3% to in 2016
15.03.2017 • About Biosyent Inc (
$RX) • By InTwits
Biosyent Inc reported FY2016 financial results today. Below you can find a comprehensive analysis of the key data driving the company's performance and stock price.
Biosyent Inc ($RX) key annual financial indicators
| mln. CAD | 2012 | 2013 | 2014 | 2015 | 2016 | 2016/2015 |
|---|
P&L
|
|---|
| Revenue | 5.024 | 7.799 | 12.211 | 15.388 | 17.922 | 16.5% |
| Gross Profit | 3.984 | 6.175 | 9.531 | 12.110 | | -100.0% |
| SG&A | 2.582 | 3.699 | 5.217 | 7.026 | | -100.0% |
| EBITDA | 1.410 | 2.454 | 4.300 | 5.119 | | -100.0% |
| Net Income | 1.541 | 1.928 | 3.154 | 3.765 | 4.310 | 14.5% |
Balance Sheet
|
|---|
| Cash | 2.316 | 4.381 | 6.989 | 4.393 | | -100.0% |
| Short Term Debt | 0.000 | 0.000 | 0.000 | 0.000 | | |
| Long Term Debt | 0.000 | 0.000 | 0.000 | 0.000 | | |
Cash flow
|
|---|
| Capex | 0.089 | 0.078 | 0.061 | 0.129 | | -100.0% |
Ratios
|
|---|
| Revenue growth | 78.9% | 55.2% | 56.6% | 26.0% | 16.5% | |
| EBITDA growth | 229.8% | 74.1% | 75.2% | 19.0% | | |
| Gross Margin | 79.3% | 79.2% | 78.1% | 78.7% | | -78.7% |
| EBITDA Margin | 28.1% | 31.5% | 35.2% | 33.3% | 0.0% | -33.3% |
| Net Income Margin | 30.7% | 24.7% | 25.8% | 24.5% | 24.0% | -0.4% |
| SG&A, % of revenue | 51.4% | 47.4% | 42.7% | 45.7% | | -45.7% |
| CAPEX, % of revenue | 1.8% | 1.0% | 0.5% | 0.8% | | -0.8% |
| ROIC | 71.7% | 62.4% | 62.9% | 48.2% | | -48.2% |
| ROE | 77.0% | 50.1% | 48.5% | 37.1% | | -37.1% |
| Net Debt/EBITDA | -1.6x | -1.8x | -1.6x | -0.9x | | 0.9x |
Biosyent Inc ($RX) key quoterly financial indicators
| mln. CAD | FY16Q1 | FY16Q2 | FY16Q3 | FY16Q4 | YoY change |
|---|
P&L
|
|---|
| Revenue | 4 | 4 | 5 | 5 | 14.1% | 21.7% | 2.6% | 30.4% |
| EBITDA | 1 | 1 | 2 | 2 | -3.9% | 19.0% | 1.7% | 57.7% |
| Net Income | 1 | 1 | 1 | 1 | -1.1% | 19.3% | 5.0% | 43.6% |
Balance Sheet
|
|---|
| Cash | 2 | 10 | 11 | 13 | -63.9% | 66.9% | 140.8% | 197.2% |
| Short Term Debt | 0 | 0 | 0 | 0 | | | | |
| Long Term Debt | 0 | 0 | 0 | 0 | | | | |
Ratios
|
|---|
| Gross Margin | 81.0% | 79.9% | 77.8% | 77.2% | 2.4% | 0.5% | 1.1% | -3.4% |
| EBITDA Margin | 33.5% | 32.0% | 34.5% | 31.8% | -6.3% | -0.7% | -0.3% | 5.5% |
| Net Income Margin | 25.2% | 23.2% | 26.2% | 21.9% | -3.9% | -0.5% | 0.6% | 2.0% |
Revenue and profitability
The company's Revenue surged on 16.5%. Revenue growth showed acceleration in FY16Q4 - it increased 30.4% YoY.
Net Income marign showed almost no change in FY2016.
Appendix 1: Peers in Consumer, Non-cyclical
Below you can find Biosyent Inc benchmarking vs. other companies in Consumer, Non-cyclical industry. It's shown for the period of 5 years for the key financial metrics. Each table has median value for all the companies in the industry together with individual financial data of the top-5 companies in the industry by particular financial metric.
Top companies by Revenue growth, %
| Top 5 | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 |
|---|
| Concordia Healthcare Corp ($CXR) | | | 159.5% | 275.7% | 107.0% |
| Heritage Global Inc ($HGP) | | -37.0% | 76.2% | 11.2% | 80.8% |
| EnerCare Inc ($ECI) | | 8.6% | 21.1% | 55.7% | 76.6% |
| CRH Medical Corp ($CRH) | | 12.5% | 56.0% | 284.2% | 70.2% |
| Nuvo Research Inc ($NRI) | | -25.3% | -29.1% | 57.0% | 31.9% |
| |
|---|
| Median (40 companies) | | 8.5% | 13.7% | 14.9% | 12.6% |
|---|
| Biosyent Inc ($RX) | | 55.2% | 56.6% | 26.0% | 16.5% |
Top companies by Gross margin, %
| Top 5 | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 |
|---|
| Cipher Pharmaceuticals Inc ($CPH) | | 99.5% | 98.3% | 92.7% | |
| Ritchie Bros Auctioneers Inc ($RBA) | 88.7% | 88.4% | 88.0% | 89.1% | 88.3% |
| Information Services Corp ($ISV) | 77.5% | 80.4% | 80.9% | 87.6% | 85.1% |
| Concordia Healthcare Corp ($CXR) | | 79.4% | 86.0% | 76.1% | 72.9% |
| Valeant Pharmaceuticals International Inc ($VRX) | 72.1% | 67.0% | 72.8% | 75.3% | 73.0% |
| |
|---|
| Median (34 companies) | 29.5% | 35.0% | 35.6% | 33.4% | 31.1% |
|---|
| Biosyent Inc ($RX) | 79.3% | 79.2% | 78.1% | 78.7% | |
Top companies by EBITDA margin, %
| Top 5 | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 |
|---|
| CRH Medical Corp ($CRH) | 21.0% | 24.5% | 29.1% | 44.1% | |
| Valeant Pharmaceuticals International Inc ($VRX) | 30.6% | 27.8% | 45.6% | 39.8% | 23.8% |
| Concordia Healthcare Corp ($CXR) | | 43.7% | 37.0% | 39.8% | -92.8% |
| Ritchie Bros Auctioneers Inc ($RBA) | 36.8% | 36.3% | 36.4% | 39.7% | 31.4% |
| EnerCare Inc ($ECI) | 52.8% | 51.0% | 45.5% | 39.3% | 26.6% |
| |
|---|
| Median (43 companies) | 9.1% | 12.0% | 12.7% | 11.0% | 10.1% |
|---|
| Biosyent Inc ($RX) | 28.1% | 31.5% | 35.2% | 33.3% | |
Top companies by CAPEX/Revenue, %
| Top 5 | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 |
|---|
| ProMetic Life Sciences Inc ($PLI) | 2.1% | 33.6% | 34.6% | 23.3% | |
| EnerCare Inc ($ECI) | 25.7% | 26.5% | 23.6% | 20.7% | 15.5% |
| Black Diamond Group Ltd ($BDI) | 61.9% | 27.5% | 31.0% | 17.6% | |
| easyhome Ltd ($EH) | 32.2% | 25.6% | 21.6% | 16.9% | 12.7% |
| K-Bro Linen Inc ($KBL) | 10.0% | 19.0% | 11.4% | 16.6% | |
| |
|---|
| Median (42 companies) | 3.1% | 2.8% | 2.4% | 2.4% | 2.1% |
|---|
| Biosyent Inc ($RX) | 1.8% | 1.0% | 0.5% | 0.8% | |
Top companies by ROIC, %
| Top 5 | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 |
|---|
| Information Services Corp ($ISV) | 71.8% | 72.8% | 58.9% | 38.1% | 27.6% |
| Colliers International Group Inc ($CIG) | 10.5% | 11.2% | 15.2% | 10.9% | 26.1% |
| Nuvo Research Inc ($NRI) | -11.6% | -17.4% | -37.9% | 12.9% | 20.8% |
| International Road Dynamics Inc ($IRD) | 0.9% | 6.7% | 4.4% | 10.6% | 16.5% |
| Premium Brands Holdings Corp ($PBH) | 10.3% | 9.9% | 6.9% | 12.6% | 15.3% |
| |
|---|
| Median (43 companies) | 8.6% | 7.5% | 8.4% | 6.3% | 8.0% |
|---|
| Biosyent Inc ($RX) | 71.7% | 62.4% | 62.9% | 48.2% | |
Top companies by Net Debt / EBITDA
| Top 5 | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 |
|---|
| Concordia Healthcare Corp ($CXR) | | -1.3x | 5.6x | 20.2x | |
| SunOpta Inc ($SOY) | 2.9x | 3.5x | 1.3x | 16.9x | 140.8x |
| Centric Health Corp ($CHH) | 5.6x | 10.2x | 11.2x | 15.6x | |
| Sienna Senior Living Inc ($SIA) | 9.5x | 11.8x | 9.2x | 9.1x | 9.1x |
| Valeant Pharmaceuticals International Inc ($VRX) | 9.5x | 10.4x | 4.0x | 7.3x | 12.7x |
| |
|---|
| Median (37 companies) | 2.9x | 2.3x | 3.5x | 2.8x | 2.8x |
|---|
| Biosyent Inc ($RX) | -1.6x | -1.8x | -1.6x | -0.9x | |
